Abstract
AbstractMarek’s disease virus (MDV) is a highly pathogenic and oncogenic alpha herpesvirus that causes Marek’s disease (MD), which is one of the most important immunosuppressive and rapid-onset neoplastic diseases in poultry. The onset of MD lymphomas and other clinical diseases can be efficiently prevented by vaccination; these vaccines are heralded as the first demonstration of a successful vaccination strategy against a cancer. However, the persistent evolution of epidemic MDV strains towards greater virulence has recently resulted in frequent outbreaks of MD in vaccinated chicken flocks worldwide. Herein, we provide an overall review focusing on the discovery and identification of the strategies by which MDV evades host immunity and attacks the immune system. We have also highlighted the decrease in the immune efficacy of current MD vaccines. The prospects, strategies and new techniques for the development of efficient MD vaccines, together with the possibilities of antiviral therapy in MD, are also discussed.
Funder
the Natural Science Foundation for Distinguished Young Scholars of Henan Province
the Key Scientific Research Projects of Universities in Henan supported by the Education Department of Henan Province
the Scientific and Technological Research Project Foundation of Henan Provincial Scientific and Technological Department
the Biotechnology and Biological Sciences Research Council (BBSRC)
Publisher
Springer Science and Business Media LLC
Reference135 articles.
1. Nair, V. et al. in Diseases of Poultry (ed Martine Boulianne David E. Swayne, Catherine M. Logue, Larry R. McDougald, Venugopal Nair, David L. Suarez, Sjaak de Wit, Tom Grimes, Deirdre Johnson, Michelle Kromm, Teguh Yodiantara Prajitno, Ian Rubinoff, Guillermo Zavala) 548-715 (John Wiley & Sons Inc, 2020).
2. Gatherer, D. et al. ICTV Virus Taxonomy Profile: Herpesviridae 2021. J. Gen. Virol. 102, 001673 (2021).
3. Witter, R. L. Increased virulence of Marek’s disease virus field isolates. Avian Dis. 41, 149–163 (1997).
4. Reddy, S. M., Izumiya, Y. & Lupiani, B. Marek’s disease vaccines: Current status, and strategies for improvement and development of vector vaccines. Vet. Microbiol. 206, 113–120 (2017).
5. Liu, J. L. et al. Emerging Hypervirulent Marek’s Disease Virus Variants Significantly Overcome Protection Conferred by Commercial Vaccines. Viruses 15, 1434 (2023).